{"id":"https://openalex.org/W1991313286","doi":"https://doi.org/10.2147/cpaa.s54308","title":"Preliminary study about the possible glycemic clinical advantage in using a fixed combination of Berberis aristata and Silybum marianum standardized extracts versus only Berberis aristata in patients with type 2 diabetes","display_name":"Preliminary study about the possible glycemic clinical advantage in using a fixed combination of Berberis aristata and Silybum marianum standardized extracts versus only Berberis aristata in patients with type 2 diabetes","alternate_titles":[],"publication_year":2013,"publication_date":"2013-11-01","ids":{"openalex":"https://openalex.org/W1991313286","doi":"https://doi.org/10.2147/cpaa.s54308","mag":"1991313286","pmid":"https://pubmed.ncbi.nlm.nih.gov/24277991","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3838471"},"language":"en","primary_location":{"id":"doi:10.2147/cpaa.s54308","doi":"https://doi.org/10.2147/cpaa.s54308","is_oa":true,"landing_page_url":"https://doi.org/10.2147/cpaa.s54308","pdf_url":"https://www.dovepress.com/getfile.php?fileID=18187","source":{"id":"https://openalex.org/S4210204454","display_name":"Clinical Pharmacology Advances and Applications","issn_l":"1179-1438","issn":["1179-1438"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","ki-jl-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology: Advances and Applications","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1991313286"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.dovepress.com/getfile.php?fileID=18187","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5072480911","display_name":"Francesco Di Pierro","orcid":"https://orcid.org/0000-0001-6654-8675","observed_orcids":["https://orcid.org/0000-0001-6654-8675","https://orcid.org/0009-0007-8876-8100"]},"institutions":[{"id":"https://openalex.org/I4210106338","display_name":"Velleja Research","ror":"https://ror.org/01e99h158","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210106338"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Francesco Di Pierro","raw_affiliation_strings":["Scientific Department, Velleja Research, Milano, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Scientific Department, Velleja Research, Milano, Italy","institution_ids":["https://openalex.org/I4210106338"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004061491","display_name":"Pietro Putignano","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210110840","display_name":"Azienda Ospedaliera San Gerardo","ror":"https://ror.org/01xf83457","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210110840"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Pietro Putignano","raw_affiliation_strings":["Outpatient Diabetic Clinic, University hospital san gerardo, Monza, italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Outpatient Diabetic Clinic, University hospital san gerardo, Monza, italy;","institution_ids":["https://openalex.org/I4210110840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108111232","display_name":"Luca Montesi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210097083","display_name":"IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola","ror":"https://ror.org/00t4vnv68","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210097083"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Luca Montesi","raw_affiliation_strings":["Diseases of Metabolism, s Orsola Malpighi hospital, Bologna, italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Diseases of Metabolism, s Orsola Malpighi hospital, Bologna, italy","institution_ids":["https://openalex.org/I4210097083"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006161156","display_name":"Simona Moscatiello","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210097083","display_name":"IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola","ror":"https://ror.org/00t4vnv68","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210097083"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Simona Moscatiello","raw_affiliation_strings":["Diseases of Metabolism, s Orsola Malpighi hospital, Bologna, italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Diseases of Metabolism, s Orsola Malpighi hospital, Bologna, italy","institution_ids":["https://openalex.org/I4210097083"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039273685","display_name":"Giulio Marchesini","orcid":"https://orcid.org/0000-0003-2407-9860","observed_orcids":["https://orcid.org/0000-0003-2407-9860"]},"institutions":[{"id":"https://openalex.org/I4210097083","display_name":"IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola","ror":"https://ror.org/00t4vnv68","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210097083"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Giulio Marchesini Reggiani","raw_affiliation_strings":["Diseases of Metabolism, s Orsola Malpighi hospital, Bologna, italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Diseases of Metabolism, s Orsola Malpighi hospital, Bologna, italy","institution_ids":["https://openalex.org/I4210097083"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5105422050","display_name":"Nicola Villanova","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210097083","display_name":"IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola","ror":"https://ror.org/00t4vnv68","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210097083"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Nicola Villanova","raw_affiliation_strings":["Diseases of Metabolism, s Orsola Malpighi hospital, Bologna, italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Diseases of Metabolism, s Orsola Malpighi hospital, Bologna, italy","institution_ids":["https://openalex.org/I4210097083"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5072480911"],"corresponding_institution_ids":["https://openalex.org/I4210106338"],"apc_list":{"value":2320,"currency":"USD","value_usd":2320},"apc_paid":{"value":2320,"currency":"USD","value_usd":2320},"fwci":3.5345,"has_fulltext":true,"cited_by_count":90,"citation_normalized_percentile":{"value":0.9207832,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"5","issue":null,"first_page":"167","last_page":"167"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12059","display_name":"Berberine and alkaloids research","score":0.9926999807357788,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12059","display_name":"Berberine and alkaloids research","score":0.9926999807357788,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11140","display_name":"Natural Antidiabetic Agents Studies","score":0.005400000140070915,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.8399999737739563},{"id":"https://openalex.org/keywords/berberine","display_name":"berberine","score":0.8859999775886536},{"id":"https://openalex.org/keywords/silymarin","display_name":"silymarin","score":0.9750000238418579},{"id":"https://openalex.org/keywords/berberis-aristata","display_name":"Berberis aristata","score":0.9369999766349792},{"id":"https://openalex.org/keywords/milk-thistle","display_name":"Silybum marianum","score":1.0},{"id":"https://openalex.org/keywords/fixed-dose-combination","display_name":"fixed-dose combination","score":0.4880000054836273},{"id":"https://openalex.org/keywords/p-glycoprotein-inhibition","display_name":"P-glycoprotein inhibition","score":0.8420000076293945},{"id":"https://openalex.org/keywords/oral-bioavailability","display_name":"oral bioavailability","score":0.8880000114440918},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.7979999780654907},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.9390000104904175},{"id":"https://openalex.org/keywords/lipid-profile","display_name":"lipid profile","score":0.777999997138977},{"id":"https://openalex.org/keywords/standardized-herbal-extract","display_name":"standardized herbal extract","score":0.5849999785423279},{"id":"https://openalex.org/keywords/adjunctive-therapy","display_name":"adjunctive therapy","score":0.7919999957084656}],"concepts":[{"id":"https://openalex.org/C2780116568","wikidata":"https://www.wikidata.org/wiki/Q176525","display_name":"Berberine","level":2,"score":0.9616421461105347},{"id":"https://openalex.org/C2780210117","wikidata":"https://www.wikidata.org/wiki/Q193798","display_name":"Silybum marianum","level":2,"score":0.9451490640640259},{"id":"https://openalex.org/C2780473172","wikidata":"https://www.wikidata.org/wiki/Q5572518","display_name":"Glycemic","level":3,"score":0.7173202037811279},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6383525729179382},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5669623613357544},{"id":"https://openalex.org/C2909423643","wikidata":"https://www.wikidata.org/wiki/Q193798","display_name":"Milk Thistle","level":2,"score":0.5512871146202087},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.5168641209602356},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.4173867404460907},{"id":"https://openalex.org/C556039675","wikidata":"https://www.wikidata.org/wiki/Q771035","display_name":"Traditional medicine","level":1,"score":0.4010198712348938},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.2250034213066101}],"mesh":[],"locations_count":8,"locations":[{"id":"doi:10.2147/cpaa.s54308","doi":"https://doi.org/10.2147/cpaa.s54308","is_oa":true,"landing_page_url":"https://doi.org/10.2147/cpaa.s54308","pdf_url":"https://www.dovepress.com/getfile.php?fileID=18187","source":{"id":"https://openalex.org/S4210204454","display_name":"Clinical Pharmacology Advances and Applications","issn_l":"1179-1438","issn":["1179-1438"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","ki-jl-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology: Advances and Applications","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:2823809","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3838471","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:24277991","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24277991","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical pharmacology : advances and applications","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:3838471","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3838471/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clin Pharmacol","raw_type":"Text"},{"id":"pmh:oai:cris.unibo.it:11585/258096","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/11585/258096","pdf_url":null,"source":{"id":"https://openalex.org/S4306402579","display_name":"Archivio istituzionale della ricerca (Alma Mater Studiorum Universit\u00e0 di Bologna)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210117483","host_organization_name":"Istituto di Ematologia di Bologna","host_organization_lineage":["https://openalex.org/I4210117483"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:doaj.org/article:93d0c4e38f974b9dbe11721c91af0757","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/93d0c4e38f974b9dbe11721c91af0757","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Clinical Pharmacology: Advances and Applications, Vol 2013, Iss Issue 1, Pp 167-174 (2013)","raw_type":"article"},{"id":"pmh:oai:dovepress.com/15020","doi":null,"is_oa":true,"landing_page_url":"https://www.dovepress.com/preliminary-study-about-the-possible-glycemic-clinical-advantage-in-us-peer-reviewed-article-CPAA","pdf_url":null,"source":{"id":"https://openalex.org/S4306401012","display_name":"Dove Medical Press (Taylor and Francis Group)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.786.9111","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.786.9111","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"ftp://ftp.ncbi.nlm.nih.gov/pub/pmc/4b/a6/cpaa-5-167.PMC3838471.pdf","raw_type":"text"}],"best_oa_location":{"id":"doi:10.2147/cpaa.s54308","doi":"https://doi.org/10.2147/cpaa.s54308","is_oa":true,"landing_page_url":"https://doi.org/10.2147/cpaa.s54308","pdf_url":"https://www.dovepress.com/getfile.php?fileID=18187","source":{"id":"https://openalex.org/S4210204454","display_name":"Clinical Pharmacology Advances and Applications","issn_l":"1179-1438","issn":["1179-1438"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","ki-jl-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology: Advances and Applications","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1991313286.pdf","grobid_xml":"https://content.openalex.org/works/W1991313286.grobid-xml"},"referenced_works_count":45,"referenced_works":["https://openalex.org/W5241709","https://openalex.org/W1968151387","https://openalex.org/W1969395627","https://openalex.org/W1972659108","https://openalex.org/W1973195425","https://openalex.org/W1978478068","https://openalex.org/W1985065867","https://openalex.org/W1989314580","https://openalex.org/W1998254400","https://openalex.org/W2008978505","https://openalex.org/W2009141930","https://openalex.org/W2011857098","https://openalex.org/W2012565726","https://openalex.org/W2017097013","https://openalex.org/W2020239768","https://openalex.org/W2035194606","https://openalex.org/W2038231515","https://openalex.org/W2043826108","https://openalex.org/W2043996770","https://openalex.org/W2045828440","https://openalex.org/W2057482589","https://openalex.org/W2068708312","https://openalex.org/W2076359557","https://openalex.org/W2084138582","https://openalex.org/W2102880109","https://openalex.org/W2106178925","https://openalex.org/W2116276162","https://openalex.org/W2122318406","https://openalex.org/W2125734273","https://openalex.org/W2127125241","https://openalex.org/W2129582474","https://openalex.org/W2132279891","https://openalex.org/W2135424573","https://openalex.org/W2141987510","https://openalex.org/W2147542963","https://openalex.org/W2162698740","https://openalex.org/W2184338251","https://openalex.org/W2324873529","https://openalex.org/W2477872031","https://openalex.org/W2497721881","https://openalex.org/W2564042923","https://openalex.org/W4230870013","https://openalex.org/W4241497896","https://openalex.org/W4300748935","https://openalex.org/W6978981909"],"related_works":["https://openalex.org/W2068708312","https://openalex.org/W2473590450","https://openalex.org/W3032912737","https://openalex.org/W2739976949","https://openalex.org/W1142305748","https://openalex.org/W2786334561","https://openalex.org/W2909693419","https://openalex.org/W2117701880"],"abstract_inverted_index":{"BACKGROUND:":[0],"Berberine":[1],"is":[2,37],"an":[3,47,150],"isoquinoline":[4],"alkaloid":[5],"widely":[6],"used":[7],"to":[8,30,66,84,97,108,167,236,252],"improve":[9],"the":[10,40,58,86,142,178,241,265,270],"glucidic":[11],"and":[12,21,135,206,225,249,268],"lipidic":[13],"profiles":[14],"of":[15,27,44,106,138,141,154,159,170,182,189,201,204,209,247,272],"patients":[16,109,119,148],"with":[17,110,120,131],"hypercholesterolemia,":[18],"metabolic":[19],"syndrome,":[20],"type":[22,111,121,276],"2":[23,112,122,277],"diabetes.":[24,113],"The":[25,81,115,147,245],"limitation":[26],"berberine":[28,56,205,248,257],"seems":[29],"be":[31,75,253],"its":[32,63],"poor":[33],"oral":[34],"bioavailability,":[35],"which":[36],"affected":[38],"by":[39,89,240],"presence,":[41],"in":[42,104,124,136,163,195,259,269,275],"enterocytes,":[43],"P-glycoprotein":[45,78,92],"-":[46],"active":[48],"adenosine":[49],"triphosphate":[50],"(ATP)-consuming":[51],"efflux":[52],"protein":[53],"that":[54],"extrudes":[55],"into":[57],"intestinal":[59],"lumen,":[60],"thus":[61],"limiting":[62],"absorption.":[64],"According":[65],"some":[67],"authors,":[68],"silymarin,":[69],"derived":[70],"from":[71],"Silybum":[72,190],"marianum,":[73],"could":[74],"considered":[76],"a":[77,90,98,156,174,186,198,237],"antagonist.":[79],"AIM:":[80],"study":[82,116],"aimed":[83],"evaluate":[85],"role":[87],"played":[88],"possible":[91],"antagonist":[93],"(silymarin),":[94],"when":[95,262],"added":[96],"product":[99],"containing":[100,177],"Berberis":[101,160,183],"aristata":[102,161,184],"extract,":[103],"terms":[105],"benefits":[107],"METHODS:":[114],"enrolled":[117],"69":[118],"diabetes":[123],"suboptimal":[125],"glycemic":[126],"control":[127],"who":[128],"were":[129,234],"treated":[130],"diet,":[132],"hypoglycemic":[133],"drugs,":[134],"cases":[137],"concomitant":[139],"alterations":[140],"lipid":[143],"profile,":[144],"hypolipidemic":[145],"agents.":[146],"received":[149],"add-on":[151],"therapy":[152],"consisting":[153],"either":[155],"standardized":[157,180,187,273],"extract":[158,181,188],"(titrated":[162,192],"85%":[164],"berberine)":[165],"corresponding":[166],"1,000":[168,202],"mg/day":[169,203,208],"berberine,":[171],"or":[172],"Berberol\u00ae,":[173],"fixed":[175,242],"combination":[176],"same":[179,266],"plus":[185],"marianum":[191],"as":[193],">60%":[194],"silymarin),":[196],"for":[197],"total":[199,218],"intake":[200],"210":[207],"silymarin.":[210],"RESULTS:":[211],"Both":[212],"treatments":[213],"similarly":[214],"improved":[215],"fasting":[216],"glucose,":[217],"cholesterol,":[219,223],"low-density":[220],"lipoprotein":[221],"(LDL)":[222],"triglyceride,":[224],"liver":[226],"enzyme":[227],"levels,":[228],"whereas":[229],"glycosylated":[230],"hemoglobin":[231],"(HbA1c)":[232],"values":[233],"reduced":[235],"greater":[238],"extent":[239],"combination.":[243],"CONCLUSION:":[244],"association":[246],"silymarin":[250],"demonstrated":[251],"more":[254],"effective":[255],"than":[256],"alone":[258],"reducing":[260],"HbA1c,":[261],"administered":[263],"at":[264],"dose":[267],"form":[271],"extracts":[274],"diabetic":[278],"patients.":[279]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1991313286","counts_by_year":[{"year":2026,"cited_by_count":7},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":7},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":9},{"year":2020,"cited_by_count":10},{"year":2019,"cited_by_count":10},{"year":2018,"cited_by_count":10},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":10},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":3}],"updated_date":"2026-11-19T14:11:59.513116","created_date":"2016-06-24T00:00:00"}
